Saranas
Houston, US · Founded 2013 · Delaware corporation · 8 employees on LinkedIn · 3 known investors
Find your way into Saranas
459 people in our graph share verified history with the Saranas team — schools, employers, funds. One of them is your warm intro.
Anthony Philippakisunlockedknows Michael Magnani · together at Harvard Medical School (overlapped)
knows the team · via Harvard Medical School
×2knows the team · via MIT Sloan School of Management
knows the team · via UC San Diego
×4knows the team · via ZS Associates
×3knows the team · via Amgen
Founders & leadership
MM

Michael MagnaniinPresident & Chief Executive Officer2013–2017Michael Magnani holds an MBA from MIT Sloan School of Management and an MS in Biomedical Enterprise from Harvard Medical School, along with a BS in Microbiology from UC San Diego. He brings over 24 years of healthcare and life sciences experience, including roles in business development, strategic planning, and medical device commercialization.
MR
Mehdi RazaviNamed on SEC filing
Board
GM
Gill M. JackBoard director
MM
Milton MorrisBoard director
DS
Daniel SteppeBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$29.2M disclosed across 6 rounds · 2015–2021
▶$15.5MraisedJul 2021 · 65 investors · OtherRule 506(b)
▶$15.5MraisedJul 2021 · 65 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Brian R. SmithDirector
- Dan WoltermanDirector
- Amy KobeDirector
- Daniel HawkinsDirector
- James ReinsteinExecutive Officer, Director
- Offering amount
- $20.5M
- Amount sold
- $15.5M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedMay 2020 · 39 investors · Other Health CareRule 506(b)
▶$1.7MraisedMay 2020 · 39 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mehdi RazaviDirector
- James ReinsteinExecutive Officer, Director
- John HuffDirector
- Milton MorrisDirector
- Kevin MaplesDirector
- Larry LawsonDirector
- Daniel HawkinsDirector
- Offering amount
- $2M
- Amount sold
- $1.7M
- Minimum investment
- $2K
- Proceeds to insiders
- $250K
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.8MraisedMay 2018 · 32 investors · Other Health CareRule 506(b)
▶$2.8MraisedMay 2018 · 32 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Larry LawsonDirector
- Mehdi RazaviDirector
- Zaffer SyedExecutive Officer, Director
- Kevin MaplesDirector
- Milton MorrisDirector
- Offering amount
- $2.8M
- Amount sold
- $2.8M
- Minimum investment
- $8K
- Proceeds to insiders
- $220K
- First sale
- May 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.3MraisedMay 2017 · 28 investors · Other Health CareRule 506(b)
▶$3.3MraisedMay 2017 · 28 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Zaffer SyedExecutive Officer, Director
- Larry LawsonDirector
- Maples KevinDirector
- Mehdi RazaviDirector
- Milton MorrisDirector
- Offering amount
- $4M
- Amount sold
- $3.3M
- Minimum investment
- $20K
- Proceeds to insiders
- $220K
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$1.4MraisedJul 2016 · 14 investors · Other Health CareRule 506(b)
▶$1.4MraisedJul 2016 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael MagnaniExecutive Officer, Director
- Milton MorrisDirector
- Mehdi RazaviExecutive Officer, Director
- Jack GillDirector
- Larry LawsonDirector
- Offering amount
- $3.5M
- Amount sold
- $1.4M
- Minimum investment
- $5K
- Proceeds to insiders
- $120K
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$4.5MraisedJun 2015 · 17 investors · Other Health CareRule 506(b)
▶$4.5MraisedJun 2015 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gill M. JackDirector
- Michael MagnaniExecutive Officer, Director
- Milton MorrisDirector
- Mehdi RazaviExecutive Officer, Director
- Daniel SteppeDirector
- Offering amount
- $4.5M
- Amount sold
- $4.5M
- Minimum investment
- $25K
- Proceeds to insiders
- $150K
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Saranas's investors?
- Saranas's investors include Houston Angel Network, S3 Ventures, Baird Capital.
- How much funding has Saranas raised?
- Saranas has disclosed $29.2M raised across 6 rounds.
- Where is Saranas headquartered?
- Saranas is headquartered in Houston, US.




